Australia markets closed

Inovio Pharmaceuticals, Inc. (INO.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
174.00-9.99 (-5.43%)
As of 08:09AM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
832.01
832.01
10,262
1,775
7,411
Operating expenses
Research development
86,677
86,677
187,651
249,240
94,245
Selling general and administrative
47,582
47,582
90,185
53,752
37,248
Total operating expenses
134,259
134,259
277,836
302,993
131,493
Operating income or loss
-133,427
-133,427
-267,574
-301,218
-124,082
Interest expense
1,223
1,223
1,254
1,936
8,702
Total other income/expenses net
-8,601
-8,601
-13,607
-3,433
-33,418
Income before tax
-135,117
-135,117
-277,653
-303,224
-162,890
Income tax expense
-
-
-
0
0
Income from continuing operations
-135,117
-135,117
-279,818
-303,659
-167,475
Net income
-135,117
-135,117
-279,818
-303,659
-166,411
Net income available to common shareholders
-135,117
-135,117
-279,818
-303,659
-166,411
Basic EPS
-1.17
-6.09
-14.07
-17.45
-12.84
Diluted EPS
-1.17
-6.09
-14.07
-17.45
-12.84
Basic average shares
238,622
22,174
19,885
17,402
12,927
Diluted average shares
238,622
22,174
19,885
17,402
12,927